Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07536412 · ClinicalTrials.gov registry record · NA
Decision Aid Efficacy in Low Risk Thyroid Cancer
A NA study, sponsored by University of Maryland, Baltimore.
- Not yet
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT07536412 is a NA study that has not yet begun recruiting, run by University of Maryland, Baltimore. The registered enrollment target is 34 participants.
The verdict
NCT07536412, a NA study, has not yet begun recruiting, sponsored by University of Maryland, Baltimore.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
Low-risk thyroid cancer grows very slowly. More than 99% of patients with this cancer survive for at least 5 years. There are 3 main treatment options: remove the whole thyroid, remove just the part of the thyroid with the cancer in it, or leave the cancer in the thyroid and monitor it. Survival is similar across the 3 main treatment options. It can be difficult for patients to choose a treatment option, especially when feeling anxious about the cancer diagnosis. In this study, enrolled patients will receive a decision aid after finding out they have cancer but before meeting a surgeon. This decision aid is a pamphlet. It gives information about the treatment options and a list of questions for patients to ask their surgeons at their clinic visit. The investigators will test whether this aid changes patient decision anxiety and decision readiness.
Interventions
- OTHER Decision Aid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2026-05-15 |
| Est. Completion | 2029-06-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07536412
The ClinicalTrials.gov registry entry for NCT07536412 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Decision Aid is the first listed.
NCT07536412 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07536412 about?
NCT07536412 is a clinical study titled "Decision Aid Efficacy in Low Risk Thyroid Cancer". Low-risk thyroid cancer grows very slowly. More than 99% of patients with this cancer survive for at least 5 years. There are 3 main treatment options: remove the whole thyroid, remove just the part of the thyroid with the cancer in it, or leave the cancer in the thyroid and monitor it. Survival is ...
What is the current status of trial NCT07536412?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 34 participants. The study started on 2026-05-15. Estimated completion is 2029-06-15.
What interventions are being tested in trial NCT07536412?
The interventions under investigation include: Decision Aid (OTHER).
Who is sponsoring clinical trial NCT07536412?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.